CD274 and neoplasm: Significant transcriptomics changes in tumor biopsies from pre-treatment to 2 weeks after axi-cel with the upregulation of immune checkpoint encoding genes (CD274, CD276, and CTLA-4) were also associated with response to therapy [61].